Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen gains over 1 billion in capitalization thanks to Alzheimer’s pipeline
Biogen gains over 1 billion in capitalization thanks to Alzheimer’s pipeline
Biogen gains over 1 billion in capitalization thanks to Alzheimer’s pipeline
Submitted by
admin
on August 17, 2017 - 11:47pm
Source:
GoInPharma
News Tags:
Biogen
Alzheimer's disease
aducanumab
Headline:
Biogen gains over 1 billion in capitalization thanks to Alzheimer’s pipeline
Do Not Allow Advertisers to Use My Personal information
